/Remote Monitoring for Biomarkers
Invite

Pending to review

Not sure yet

Interested

Not interested

Showing 28 companies

Get more companies

Download list

Company
Fit assessment
Description
Subspaces
Tags
HQ Location
Founded
Employees
Total Funding Raised
Last Funding Event
Received on
Top picks for your space
Cogniant

Cogniant effectively employs remote monitoring technologies to advance clinical trials and identify digital biomarkers, contributing to the development of innovative health solutions.

Cogniant is an AI-assisted digital health platform for monitoring chronic and mental health conditions. Cogniant collects thousands of data points of clients’ daily routines via devices and smartphone sensors. This allows for behavior monitoring whilst educating clients towards better treatment outcomes and connecting them to caregivers and providers for chronic and co-morbid mental health conditions.
  • Digital Biomarkers Development
Light Search
Singapore (Singapore)20151 - 10$120.00KPre-Seed, $120.00K, January 10, 2021
9 months ago
DigiBio

DigiBiomarkers effectively utilizes remote monitoring technologies to enhance clinical trials and identify digital biomarkers for health tracking.

DigiBiomarkers provides a platform for capturing frequent and objective patient-level data. The company focuses on enabling healthcare providers to collect and analyze biometric data through digital means. This data helps in monitoring patient health and improving clinical outcomes. DigiBiomarkers leverages technology to facilitate better decision-making in healthcare settings.
  • Digital Biomarkers Development
Light Search
Carmel (United States)20161 - 10NA
9 months ago
Biofourmis

Biofourmis excels in remote patient monitoring, advancing clinical trials, and identifying digital biomarkers, making it a strong fit for the specified requirements.

Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics. The company discovers, develops, and delivers clinically validated software-based therapeutics to enable better outcomes for patients. These solutions include advanced tools for clinicians to deliver personalized care and cost-effective solutions for payers. Biofourmis was founded in 2015 and headquartered in Boston, Massachusetts.
  • Digital Biomarkers Development
With Momentum
Light Search
Boston (United States)2015201 - 500$463.57MAcquired, October 2024
9 months ago